New combo ablation aims to stop AFib in its tracks

NCT ID NCT07171463

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new approach for treating paroxysmal atrial fibrillation (a type of irregular heartbeat). It combines two procedures: pulsed-field ablation to isolate the pulmonary veins, plus targeted thermal ablation of a nerve cluster near the heart. The goal is to see if adding the thermal step reduces AFib recurrence and dangerous slow heart rates during the procedure. Twenty adults with documented paroxysmal AFib will be randomly assigned to receive either the standard ablation or the combo treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pulsed-field ablation and radiofrequency ablation
What this could lead to
If successful, this combination approach could reduce AFib recurrence and the need for repeat procedures.
What could go wrong
This is a very small early-stage trial with only 20 participants, so results may not apply broadly. The added thermal ablation also carries risks like nerve damage or heart tissue injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St. Joseph's Heart Rhythm Center

    RECRUITING

    Rzeszów, Podkarpackie Voivodeship, 35-623, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.